ELV – Elevance Health Inc.
ELV — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1.67
Margin Of Safety %
6
Put/Call OI Ratio
0.76
EPS Next Q Diff
3.27
EPS Last/This Y
0.73
EPS This/Next Y
3.44
Price
286.32
Target Price
375.8
Analyst Recom
2.04
Performance Q
-16.58
Upside
92.9%
Beta
0.5
Ticker: ELV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | ELV | 320.08 | 0.68 | 0.59 | 28256 |
| 2026-03-03 | ELV | 283.98 | 0.70 | 0.78 | 30859 |
| 2026-03-04 | ELV | 291.47 | 0.69 | 0.44 | 31541 |
| 2026-03-06 | ELV | 289.53 | 0.66 | 0.83 | 34447 |
| 2026-03-09 | ELV | 280.67 | 0.65 | 1.54 | 34976 |
| 2026-03-10 | ELV | 282.82 | 0.69 | 3.77 | 36565 |
| 2026-03-11 | ELV | 289.79 | 0.65 | 1.20 | 35930 |
| 2026-03-12 | ELV | 287.9 | 0.72 | 0.42 | 43665 |
| 2026-03-13 | ELV | 287.89 | 0.72 | 0.46 | 43665 |
| 2026-03-17 | ELV | 296.82 | 0.70 | 1.21 | 44811 |
| 2026-03-18 | ELV | 295.07 | 0.71 | 1.29 | 44977 |
| 2026-03-20 | ELV | 291.6 | 0.70 | 0.80 | 44996 |
| 2026-03-25 | ELV | 296.13 | 0.78 | 0.48 | 34223 |
| 2026-03-26 | ELV | 294.22 | 0.78 | 0.20 | 34539 |
| 2026-03-27 | ELV | 286.31 | 0.76 | 0.04 | 35148 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | ELV | 319.98 | -11.8 | -83.3 | 26.05 |
| 2026-03-02 | ELV | 294.06 | -11.8 | -610.9 | 26.05 |
| 2026-03-03 | ELV | 283.77 | -11.8 | -327.7 | 26.05 |
| 2026-03-04 | ELV | 291.61 | -11.8 | 37.0 | 26.05 |
| 2026-03-05 | ELV | 286.37 | -11.8 | -223.0 | 26.05 |
| 2026-03-06 | ELV | 289.66 | -11.8 | -51.8 | 26.05 |
| 2026-03-09 | ELV | 280.57 | -11.8 | -304.9 | 26.05 |
| 2026-03-10 | ELV | 282.79 | -11.8 | -77.0 | 26.05 |
| 2026-03-11 | ELV | 289.78 | -11.8 | 27.6 | 26.05 |
| 2026-03-12 | ELV | 287.97 | -10.9 | -156.9 | 26.02 |
| 2026-03-13 | ELV | 291.69 | -10.9 | -42.0 | 26.02 |
| 2026-03-17 | ELV | 295.83 | -10.8 | -43.6 | 26.01 |
| 2026-03-18 | ELV | 294.97 | -10.8 | -135.5 | 26.01 |
| 2026-03-19 | ELV | 291.18 | -10.8 | -757.6 | 26.01 |
| 2026-03-20 | ELV | 291.48 | -10.8 | -679.4 | 26.01 |
| 2026-03-23 | ELV | 289.27 | -10.8 | -728.7 | 26.01 |
| 2026-03-24 | ELV | 290.33 | -10.8 | -666.4 | 26.01 |
| 2026-03-25 | ELV | 296.05 | -10.8 | -578.8 | 26.01 |
| 2026-03-26 | ELV | 294.16 | -10.8 | -723.0 | 26.01 |
| 2026-03-27 | ELV | 286.32 | -10.8 | -835.6 | 26.01 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | ELV | 0.00 | -0.25 | 2.11 |
| 2026-03-02 | ELV | 0.00 | 1.53 | 2.11 |
| 2026-03-03 | ELV | 0.00 | 1.53 | 2.11 |
| 2026-03-04 | ELV | 0.00 | 1.53 | 2.11 |
| 2026-03-05 | ELV | 0.00 | 1.53 | 2.11 |
| 2026-03-06 | ELV | 0.49 | 1.53 | 2.11 |
| 2026-03-09 | ELV | -0.03 | 1.53 | 2.11 |
| 2026-03-10 | ELV | -0.03 | 1.53 | 2.11 |
| 2026-03-11 | ELV | -0.03 | 1.53 | 1.92 |
| 2026-03-12 | ELV | -0.03 | 1.53 | 1.92 |
| 2026-03-13 | ELV | -0.03 | 1.53 | 1.92 |
| 2026-03-17 | ELV | -0.03 | 1.49 | 1.92 |
| 2026-03-18 | ELV | -0.03 | 1.49 | 1.92 |
| 2026-03-19 | ELV | -0.03 | 1.49 | 1.92 |
| 2026-03-20 | ELV | -0.03 | 1.49 | 1.92 |
| 2026-03-23 | ELV | -0.04 | 1.49 | 1.92 |
| 2026-03-24 | ELV | -0.04 | 1.49 | 1.92 |
| 2026-03-25 | ELV | -0.04 | 1.49 | 1.67 |
| 2026-03-26 | ELV | -0.04 | 1.49 | 1.67 |
| 2026-03-27 | ELV | -0.04 | 1.49 | 1.67 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3.33
Avg. EPS Est. Current Quarter
10.68
Avg. EPS Est. Next Quarter
6.6
Insider Transactions
-0.04
Institutional Transactions
1.49
Beta
0.5
Average Sales Estimate Current Quarter
48382
Average Sales Estimate Next Quarter
48532
Fair Value
302.56
Quality Score
62
Growth Score
75
Sentiment Score
47
Actual DrawDown %
49.5
Max Drawdown 5-Year %
-50.4
Target Price
375.8
P/E
11.41
Forward P/E
9.86
PEG
2.26
P/S
0.32
P/B
1.44
P/Free Cash Flow
19.91
EPS
25.11
Average EPS Est. Cur. Y
26.01
EPS Next Y. (Est.)
29.44
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
2.84
Relative Volume
0.71
Return on Equity vs Sector %
-14.4
Return on Equity vs Industry %
2.4
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.06
EBIT Estimation
-835.6
◆
ELV
Healthcare
$286.39
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
37.1
Range 1M
27.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-14.6%
EPS NY
12.3%
52W%
6.7%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+71% upside
Upside
+71%
Quality
62
MoS
6%
Elevance Health, Inc.Sector: Healthcare
Industry: Healthcare Plans
Employees: 96129
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
ELV
Latest News
—
Caricamento notizie per ELV…
stock quote shares ELV – Elevance Health Inc. Stock Price stock today
news today ELV – Elevance Health Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ELV – Elevance Health Inc. yahoo finance google finance
stock history ELV – Elevance Health Inc. invest stock market
stock prices ELV premarket after hours
ticker ELV fair value insiders trading